relatlimab
Sign in to saveAlso known as BMS-986016
Relatlimab is a monoclonal antibody designed for the treatment of melanoma. It is used in combination with nivolumab to treat melanoma.
~2 min read
Encyclopedic overview
3 sectionsContents
- History
- Names
- References
Relatlimab is a monoclonal antibody designed for the treatment of melanoma. It is used in combination with nivolumab to treat melanoma.
Relatlimab is a Lymphocyte activation gene-3 (LAG-3) inhibitor. It is under development by Bristol-Myers Squibb. It is made using Chinese hamster ovary cells.
Excerpted from Wikipedia’s “relatlimab” article, available under the CC BY-SA 4.0 licence.